{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:15:24Z","timestamp":1783073724819,"version":"3.54.6"},"reference-count":22,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Colombian Registry of Haemophilia and other Coagulopathies (CRHOC) was established in 2014 to centralize nationwide data on haemophilia patients through mandatory reporting by all treatment centres and healthcare payers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe 10\u2010year trends in epidemiological patterns, treatment access, and health outcomes among individuals with haemophilia reported to the CRHOC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This longitudinal analysis included all haemophilia patients reported to the CRHOC between February 2014 and January 2024. Sociodemographic and clinical characteristics, treatment patterns, and quality\u2010of\u2010care indicators were analysed. Data underwent standardized quality assurance procedures, including validation frameworks and medical record verification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2014 to 2024, 3699 people with haemophilia were reported (83.1% haemophilia A; 16.9% haemophilia B). Prevalence increased over time, while prevalence of high\u2010titre inhibitor declined for both types. Prophylaxis coverage exceeded 95% in children and 85% in adults with severe haemophilia. Treatment patterns shifted notably, with increased adoption of extended half\u2010life products and emicizumab for haemophilia A. The prevalence of chronic arthropathy remained stable in children but increased in adults, despite widespread use of prophylaxis. Access to multidisciplinary care improved significantly over the decade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Over ten years, the CRHOC has documented substantial improvements in haemophilia care in Colombia, including near\u2010universal access to prophylaxis, reduced inhibitor prevalence, and increased use of innovative therapies. The consistent expansion of multidisciplinary care has enhanced patient management. As a comprehensive national registry, the CRHOC provides high\u2010quality data to inform evidence\u2010based health policy decisions and serves as a model for improving clinical outcomes in rare disease management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Remark<\/jats:title>\n                    <jats:p>\n                      <jats:bold>1) Why was this study conducted?<\/jats:bold>\n                      This study was conducted to describe and analyse the 10\u2010year trends in epidemiological patterns, treatment access, and health outcomes among people with haemophilia reported to the Colombian Registry of Haemophilia and other Coagulopathies (CRHOC) since its establishment in 2014. As one of the comprehensive registries in the region, the CRHOC provides a unique opportunity to evaluate the impact of Colombia's national strategy for integrated haemophilia care.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>2) What were the most relevant results of the study?<\/jats:bold>\n                      Key findings include: (1) a progressive increase in the number of identified people with haemophilia, accompanied by declining high\u2010titre inhibitor prevalence in both haemophilia A and B; (2) high prophylaxis coverage, exceeding 95% in children and 85% in adults with severe haemophilia; (3) a marked shift in treatment paradigms, with broader adoption of extended half\u2010life products and emicizumab in haemophilia A; (4) stable prevalence of chronic haemophilic arthropathy in children but increasing prevalence among adults despite widespread prophylaxis use; and (5) progressive improvements in access to multidisciplinary care over the decade, reflecting the expansion of comprehensive haemophilia care in Colombia.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>3) What do these results contribute?<\/jats:bold>\n                      These findings provide robust evidence on the effectiveness of a national registry in enhancing clinical outcomes and optimizing healthcare delivery for people with haemophilia. The CRHOC exemplifies how systematic data collection can both inform policy decisions and clinical practices, ultimately driving improvements in patients care. Moreover, the findings highlight both achievements and ongoing challenges in haemophilia management, offering transferable lessons for other middle\u2010income countries implementing registry\u2010based strategies. This ten\u2010year analysis also serves as a critical benchmark for evaluating long\u2010term outcomes within comprehensive haemophilia care programmes globally.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hae.70344","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:16:41Z","timestamp":1783070201000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten\u2010year Demographic and Clinical Characterisation of People With Haemophilia: The Colombian Registry Experience"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-7507","authenticated-orcid":false,"given":"Adriana Esperanza","family":"Pe\u00f1uela S\u00e1nchez","sequence":"first","affiliation":[{"name":"Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo  Bogot\u00e1 D.C. Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-3869","authenticated-orcid":false,"given":"Lina Johana","family":"Herrera Parra","sequence":"additional","affiliation":[{"name":"Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo  Bogot\u00e1 D.C. Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-6850","authenticated-orcid":false,"given":"Adriana","family":"Linares","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Hospital Pedi\u00e1trico La Misericordia  Bogot\u00e1 D.C. Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3668-311X","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"Valbuena\u2010Garc\u00eda","sequence":"additional","affiliation":[{"name":"Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo  Bogot\u00e1 D.C. Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Solano","sequence":"additional","affiliation":[{"name":"Hospital De San Jos\u00e9 \u2010 FUCS  Bogot\u00e1 D.C. Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-6991","authenticated-orcid":false,"given":"Lizbeth","family":"Acu\u00f1a Merch\u00e1n","sequence":"additional","affiliation":[{"name":"Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo  Bogot\u00e1 D.C. Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/M19\u20101208"},{"key":"e_1_2_10_4_1","unstructured":"National Department of Statistics.National population projections by area 2020\u20132035. Post Covid\u201019 update.Bogot\u00e1 D.C.;2023."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.15446\/rsap.v20n6.78585"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14138"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13607"},{"key":"e_1_2_10_8_1","unstructured":"Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de Alto Costo.Situaci\u00f3n de la hemofilia y otras coagulopat\u00edas en Colombia 2022.Bogot\u00e1 D.C.;2023 https:\/\/cuentadealtocosto.org\/situacion\u2010de\u2010la\u2010hemofilia\u2010y\u2010otras\u2010coagulopatias\u2010en\u2010colombia\u20102022\u20102\/."},{"key":"e_1_2_10_9_1","unstructured":"World Federation of Hemophilia. WFH report on the annual global survey 2024 Montreal (QC): World Federation of Hemophilia;2025 https:\/\/www1.wfh.org\/publications\/files\/pdf\u20102588.pdf."},{"key":"e_1_2_10_10_1","unstructured":"Ministerio de Salud y Protecci\u00f3n Social.Cifras de afiliaci\u00f3n en salud [Internet].2023 https:\/\/www.minsalud.gov.co\/proteccionsocial\/Paginas\/cifras\u2010aseguramiento\u2010salud.aspx."},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14136"},{"key":"e_1_2_10_12_1","unstructured":"Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de Alto Costo.Situaci\u00f3n de la hemofilia y otras coagulopat\u00edas en Colombia 2024.Bogot\u00e1 D.C.;2025 https:\/\/cuentadealtocosto.org\/situacion\u2010de\u2010la\u2010hemofilia\u2010y\u2010otras\u2010coagulopatias\u2010en\u2010colombia\u20102024\/."},{"key":"e_1_2_10_13_1","volume-title":"Resoluci\u00f3n 123 de 2015, por la Cual se Establece el Reporte de Informaci\u00f3n de Personas con Hemofilia y Otras Coagulopat\u00edas","author":"Ministerio de Salud y Protecci\u00f3n Social de Colombia","year":"2015"},{"key":"e_1_2_10_14_1","unstructured":"Ministerio de Salud y Protecci\u00f3n Social.Cifras de afiliaci\u00f3n en salud.Bogot\u00e1 D.C.;2025 https:\/\/www.minsalud.gov.co\/Proteccion\u2010Social\/Paginas\/cifras\u2010aseguramiento\u2010salud.aspx."},{"key":"e_1_2_10_15_1","unstructured":"Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de Alto Costo.Consenso basado en la evidencia: indicadores necesarios para evaluar los resultados en gesti\u00f3n del riesgo en pacientes con diagn\u00f3stico de hemofilia A o B para aseguradores y prestadores en Colombia.Bogot\u00e1 D.C.2015 https:\/\/cuentadealtocosto.org\/consenso\u2010basado\u2010en\u2010evidencia\u2010indicadores\u2010de\u2010hemofilia\u20102015\/."},{"key":"e_1_2_10_16_1","unstructured":"Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de Alto Costo.Actualizaci\u00f3n del consenso basado en la evidencia: indicadores necesarios para evaluar la gesti\u00f3n del riesgo en los pacientes con hemofilia en Colombia; Bogot\u00e1 DC.2020 https:\/\/cuentadealtocosto.org\/indicadores\u2010de\u2010gestion\u2010del\u2010riesgo\u2010en\u2010pacientes\u2010con\u2010hemofilia\u2010en\u2010colombia\u20102020\u2010actualizacion\/."},{"key":"e_1_2_10_17_1","article-title":"WFH World Bleeding Disorders Registry","author":"WBDR","journal-title":"World Bleeding Disorders Registry 2022 Data report"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15182"},{"key":"e_1_2_10_19_1","unstructured":"Association of Hemophilia Clinic Directors of Canada.Canadian Bleeding Disorders Registry\u2014Hemophilia A tables [Internet].2023 https:\/\/www.ahcdc.ca\/storage\/files\/20240911110116\u2010hemophilia\u2010a\u2010tables.pdf."},{"key":"e_1_2_10_20_1","unstructured":"National Blood Authority Australia.Australian Bleeding Disorders Registry. Annual Report 2023 \u2010 24 [Internet]. Canberra;2024 https:\/\/www.blood.gov.au\/australian\u2010bleeding\u2010disorders\u2010registry\u2010annual\u2010report."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14167"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.133462"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102207"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.70344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hae.70344","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.70344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:17:04Z","timestamp":1783070224000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.70344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":22,"alternative-id":["10.1111\/hae.70344"],"URL":"https:\/\/doi.org\/10.1111\/hae.70344","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2026-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"hae.70344"}}